189 related articles for article (PubMed ID: 34726247)
21. Hydrogen sulfide restores sevoflurane postconditioning mediated cardioprotection in diabetic rats: Role of SIRT1/Nrf2 signaling-modulated mitochondrial dysfunction and oxidative stress.
Zhang J; Cai X; Zhang Q; Li X; Li S; Ma J; Zhu W; Liu X; Wei M; Tu W; Shen Y; Liu J; Lai X; Yu P
J Cell Physiol; 2021 Jul; 236(7):5052-5068. PubMed ID: 33325044
[TBL] [Abstract][Full Text] [Related]
22. Donor Heart Preservation with Hydrogen Sulfide: A Systematic Review and Meta-Analysis.
Ertugrul IA; van Suylen V; Damman K; de Koning MLY; van Goor H; Erasmus ME
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072153
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in the protective role of hydrogen sulfide in myocardial ischemia/reperfusion injury: a narrative review.
Zhang ML; Peng W; Ni JQ; Chen G
Med Gas Res; 2021; 11(2):83-87. PubMed ID: 33818448
[TBL] [Abstract][Full Text] [Related]
24. Myocardial postconditioning: next step to cardioprotection.
Rohilla A; Rohilla S; Kushnoor A
Arch Pharm Res; 2011 Sep; 34(9):1409-15. PubMed ID: 21975801
[TBL] [Abstract][Full Text] [Related]
25. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels.
Johansen D; Ytrehus K; Baxter GF
Basic Res Cardiol; 2006 Jan; 101(1):53-60. PubMed ID: 16328106
[TBL] [Abstract][Full Text] [Related]
26. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
[TBL] [Abstract][Full Text] [Related]
27. Hydrogen sulfide and cardioprotection--Mechanistic insights and clinical translatability.
Salloum FN
Pharmacol Ther; 2015 Aug; 152():11-7. PubMed ID: 25913517
[TBL] [Abstract][Full Text] [Related]
28. Hydrogen sulfide preconditioning protects against myocardial ischemia/reperfusion injury in rats through inhibition of endo/sarcoplasmic reticulum stress.
Li C; Hu M; Wang Y; Lu H; Deng J; Yan X
Int J Clin Exp Pathol; 2015; 8(7):7740-51. PubMed ID: 26339339
[TBL] [Abstract][Full Text] [Related]
29. Controlled-releasing hydrogen sulfide donor based on dual-modal iron oxide nanoparticles protects myocardial tissue from ischemia-reperfusion injury.
Wang W; Liu H; Lu Y; Wang X; Zhang B; Cong S; Zhao Y; Ji M; Tao H; Wei L
Int J Nanomedicine; 2019; 14():875-888. PubMed ID: 30787606
[TBL] [Abstract][Full Text] [Related]
30. [Effects of stimulation and blockade of the synthesis of endogenous hydrogen sulfide at myocardial ischemia-reperfusion].
Sahach VF; Shymans'ka TV; Hoshovs'ka IuV
Fiziol Zh (1994); 2013; 59(4):8-15. PubMed ID: 24175471
[TBL] [Abstract][Full Text] [Related]
31. Persulfidation of mitoKv7.4 channels contributes to the cardioprotective effects of the H
Testai L; Montanaro R; Flori L; Pagnotta E; Vellecco V; Gorica E; Ugolini L; Righetti L; Brancaleone V; Bucci M; Piragine E; Martelli A; Di Cesare Mannelli L; Ghelardini C; Calderone V
Biochem Pharmacol; 2023 Sep; 215():115728. PubMed ID: 37524208
[TBL] [Abstract][Full Text] [Related]
32. A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury.
Sun X; Wang W; Dai J; Jin S; Huang J; Guo C; Wang C; Pang L; Wang Y
Sci Rep; 2017 Jun; 7(1):3541. PubMed ID: 28615705
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of intermediate doses of hydrogen sulfide against myocardial ischemia-reperfusion injury in obese type 2 diabetic rats.
Jeddi S; Gheibi S; Kashfi K; Carlström M; Ghasemi A
Life Sci; 2020 Sep; 256():117855. PubMed ID: 32473245
[TBL] [Abstract][Full Text] [Related]
34. Delivery of Hydrogen Sulfide by Ultrasound Targeted Microbubble Destruction Attenuates Myocardial Ischemia-reperfusion Injury.
Chen G; Yang L; Zhong L; Kutty S; Wang Y; Cui K; Xiu J; Cao S; Huang Q; Liao W; Liao Y; Wu J; Zhang W; Bin J
Sci Rep; 2016 Jul; 6():30643. PubMed ID: 27469291
[TBL] [Abstract][Full Text] [Related]
35. Role of endogenous hydrogen sulfide in cardiac mitochondrial preservation during ischemia reperfusion injury.
Nandi S; Ravindran S; Kurian GA
Biomed Pharmacother; 2018 Jan; 97():271-279. PubMed ID: 29091875
[TBL] [Abstract][Full Text] [Related]
36. Involvement of MicroRNA-133a in the Protective Effect of Hydrogen Sulfide against Ischemia/Reperfusion-Induced Endoplasmic Reticulum Stress and Cardiomyocyte Apoptosis.
Ren L; Wang Q; Chen Y; Ma Y; Wang D
Pharmacology; 2019; 103(1-2):1-9. PubMed ID: 30326468
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137.
Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF
Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570
[TBL] [Abstract][Full Text] [Related]
38. Hydrogen sulfide preconditioning shows differential protection towards interfibrillar and subsarcolemmal mitochondria from isolated rat heart subjected to revascularization injury.
Ravindran S; Ansari Banu S; Kurian GA
Cardiovasc Pathol; 2016; 25(4):306-315. PubMed ID: 27167777
[TBL] [Abstract][Full Text] [Related]
39. [Protective effect of hydrogen sulfide on rats with myocardial ischemia/reperfusion injury and its mechanism].
Zhang Y; Peng L; Yu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):316-20. PubMed ID: 25744834
[TBL] [Abstract][Full Text] [Related]
40. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
